Table 4.

Markers of gut translocation and inflammation (N = 10)

	During sugar supplementation *		Between glucose and fructose supplementation **
	Glucose arm	P  =	Fructose arm	P  =	P =
	Mean (SD)		Mean (SD)
Serum I-FABP (ng/ml)	0.00 (0.1)	0.86	0.00 (0.1)	0.38	0.59
Serum sCD14 (ng/ml)	0.18 (1.9)	0.77	0.52 (1.3)	0.23	0.68
Serum LBP (ng/ml)	4.51 (8.9)	0.14	1.44 (8.9)	0.62	0.63
Fecal calprotectin (ng/ml)	4.02 (15.6)	0.44	2.29 (19.2)	0.72	0.40

I-FABP, intestinal fatty acid binding protein; sCD-14, a protein often consistent with circulating lipopolysaccharides; LBP, lipopolysaccharide binding protein.

^*Mean differences in data between study start and study end for participants in the glucose and fructose arms of the study.

^**P-values of data comparing differences from study start and end in the glucose versus fructose arms of the study.

These data all were within the normal range.